The Nucleo-reticular Multi-cell Dual-system Eye Implant consists of a spherical structure with calculated and variable axial length depending on the needs required by the orbital eye socket, composed of a cell mesh with alternative designs that in turn, makes up the MMM System, in which suturing is provided in any technique, either in cases of evisceration or enucleation. Thanks to its multi-cell structural design, it favors its placement and reduces the risk of migration, extrusion, exposure and extraction. As it is an arrangement with structural holes, it provides a higher percentage of the volume for its vascularization; it also houses inside a Reticular Fibrovascular Core System, which has a structure based on multilevels equipped with micro-reticular tissue and an intra-level communication based on filaments; with the capacity to contain medicines and/or technology by presenting a dual-system of two screw-on pieces, being able to manufacture in different structural designs and biocompatible materials. The C100 model made of polylactic acid (PLA), an ideal material for implants, consists of 100 oval cells. Since it is a light eye implant, it prevents depressure due to settlement or gravity and it can be manufactured in any size.

An implantable medical device having a package, including: a device body, and a package configured for packaging the device body. The package includes at least one organic film layer and at least one inorganic film layer that are stacked on one another. An innermost layer of the package is an organic film layer or an inorganic film layer, and an outermost layer of the package is an organic film layer or an inorganic film layer. Each organic film layer is a parylene film or polyimide resin film with biocompatibility, and each inorganic film layer is an inorganic film with biocompatibility. A method for packaging an implantable medical device is also provided.

An implantable medical device having a package, including: a device body, and a package configured for packaging the device body. The package includes at least one organic film layer and at least one inorganic film layer that are stacked on one another. An innermost layer of the package is an organic film layer or an inorganic film layer, and an outermost layer of the package is an organic film layer or an inorganic film layer. Each organic film layer is a parylene film or polyimide resin film with biocompatibility, and each inorganic film layer is an inorganic film with biocompatibility. A method for packaging an implantable medical device is also provided.

An intraocular implant device for comprehensive intraocular vision advancement includes an intraocular implant body shaped for positioning inside a lens chamber of an eye. In some embodiments, the implant includes an optical adjustable base accommodating lens configured to provide both base adjustment and accommodation. In further embodiments, the implant includes a photoelectric sensor operable to receive incident light through the cornea and to convert the received light into electrical energy for use with one or more circuit components disposed on the body, and wherein the photoelectric sensor is also operable to convert the received light into image data. The ocular implant device may include a projector for projecting the an image representative of the image data onto the retina of a user.

An imaging probe comprises a camera or endoscope with an external detector array, in which the probe is sized and shaped for surgical placement in an eye to image the eye from an interior of the eye during treatment. The imaging probe and a treatment probe can be coupled together with a fastener or contained within a housing. The imaging probe and the treatment probe can be sized and shaped to enter the eye through an incision in the cornea and image one or more of the ciliary body band or the scleral spur. The treatment probe may comprise a treatment optical fiber or a surgical placement device to deliver an implant. A processor coupled to the detector can be configured with instructions to identify a location of one or more of the ciliary body band, the scleral spur, Schwalbe's line, or Schlemm's canal from the image.

An imaging probe comprises a camera or endoscope with an external detector array, in which the probe is sized and shaped for surgical placement in an eye to image the eye from an interior of the eye during treatment. The imaging probe and a treatment probe can be coupled together with a fastener or contained within a housing. The imaging probe and the treatment probe can be sized and shaped to enter the eye through an incision in the cornea and image one or more of the ciliary body band or the scleral spur. The treatment probe may comprise a treatment optical fiber or a surgical placement device to deliver an implant. A processor coupled to the detector can be configured with instructions to identify a location of one or more of the ciliary body band, the scleral spur, Schwalbe's line, or Schlemm's canal from the image.

Embodiments concern an intraocular implantable device operable comprising a disk-shaped body having a symmetry axis and which further comprises a light-transmissive portion and an opaque portion wherein the light-transmissive portion is decentered with respect to the symmetry axis.

Embodiments concern an intraocular implantable device operable comprising a disk-shaped body having a symmetry axis and which further comprises a light-transmissive portion and an opaque portion wherein the light-transmissive portion is decentered with respect to the symmetry axis.

The present invention relates to a glaucoma implant device (1) comprising a connection portion (21) and a mesh portion (11) coupled to each other, wherein the mesh portion (11) is defined by a plurality of polygonal cells (111) arranged side-by-side in contact to each other according to a predefined number of rows and columns, wherein each of the polygonal cells (111) has perimetral sides (1111) and a through opening in-between defining a liquid collecting area (2111), wherein each of the perimetral sides (1111) defines an inner duct, the inner ducts being in hydraulic connection to each other, wherein one or more of the inner duct are in hydraulic connection with the connection potion (21) allowing the directing aqueous humour from Schlemm canal to the mesh portion (11), and wherein each of the polygonal cells (111) is provided with at least an opening (3111) at the perimetral side (1111) which connects the inner duct to the liquid collecting area (2111) allowing the draining of aqueous humour into subconjunctival or suprachoroidal space by flowing out from the inner ducts.

The present invention relates to a glaucoma implant device (1) comprising a connection portion (21) and a mesh portion (11) coupled to each other, wherein the mesh portion (11) is defined by a plurality of polygonal cells (111) arranged side-by-side in contact to each other according to a predefined number of rows and columns, wherein each of the polygonal cells (111) has perimetral sides (1111) and a through opening in-between defining a liquid collecting area (2111), wherein each of the perimetral sides (1111) defines an inner duct, the inner ducts being in hydraulic connection to each other, wherein one or more of the inner duct are in hydraulic connection with the connection potion (21) allowing the directing aqueous humour from Schlemm canal to the mesh portion (11), and wherein each of the polygonal cells (111) is provided with at least an opening (3111) at the perimetral side (1111) which connects the inner duct to the liquid collecting area (2111) allowing the draining of aqueous humour into subconjunctival or suprachoroidal space by flowing out from the inner ducts.